Brentuximab vedotin for CD30-positive tumours.

Lancet Oncol

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Published: September 2016

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30404-1DOI Listing

Publication Analysis

Top Keywords

brentuximab vedotin
4
vedotin cd30-positive
4
cd30-positive tumours
4
brentuximab
1
cd30-positive
1
tumours
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!